Immuron CEO, Steven Lydeamore to present at H.C. Wainwright

MELBOURNE, Australia, Sept. 11, 2023 (GLOBE NEWSWIRE) — Immuron Limited (ASX: IMC; NASDAQ: IMRN), an Australian based and globally integrated biopharmaceutical company is pleased to advise our Chief Executive Officer, Steven Lydeamore will be presenting virtually at the H.C. Wainwright 25^th Annual Global Investment Conference on September 11^th.